Professor David Dearnaley’s team was researching ways to better target a tumour during radiotherapy while avoiding healthy tissue around it. Professor Dearnaley retired in August 2020.
Professor David Dearnaley has been central to the development of intensity modulated radiotherapy – a new radiotherapy technique that reduces damage to healthy tissue. He ran several trials for treating prostate cancer and investigated new image-guided radiotherapy techniques. Professor Dearnaley retired in August 2020.